Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol

Analysis of estrogens in serum and plasma from postmenopausal women: Past present, and future

(2010) Ian A. Blair   STEROIDS

Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues

(2010) Seiji Arai et al.   STEROIDS

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Binary and ternary crystal structure analyses of a novel inhibitor with 17β-HSD type 1: a lead compound for breast cancer therapy

(2009) Mausumi Mazumdar et al.   BIOCHEMICAL JOURNAL

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

(2009) P.E. Lønning et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

In situestrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology

(2009) Hironobu Sasano et al.   PATHOLOGY INTERNATIONAL

New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography–tandem mass spectrometry

(2009) Seiji Arai et al.   STEROIDS

High-Sensitivity Tandem Mass Spectrometry Assay for Serum Estrone and Estradiol

(2008) Mark M. Kushnir et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy

(2008) Naoko Honma et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

(2008) Ivana Sestak et al.   LANCET ONCOLOGY